HCC, the most prevalent form of primary liver cancer, presents a substantial global health
challenge due to its high mortality and limited therapeutic options. This review delves into …

Cancer immunotherapy has revolutionized clinical cancer treatments by taking advantage of
the immune system to selectively and effectively target and kill cancer cells. However …

Molecular classification, particularly microsatellite instability-high (MSI-H), has gained
attention for immunotherapy in endometrial cancer (EC). MSI-H is associated with DNA …

Cholangiocarcinoma (CCA) is a diverse group of epithelial malignant tumors arising from
the biliary tract, characterized by high molecular heterogeneity. It is classified into …

Chimeric antigen receptor T-cell (CAR-T) treatment has been widely used in the treatment of
hematological malignancies, and its application has been gradually expanded to the …

Introduction: Lacrimal sac squamous cell carcinoma (SCC) is a rare tumor. Only 241 cases
of lacrimal sac SCC have been reported in the literature. However, the detailed molecular …

Monoclonal antibodies are a promising class of targeted anticancer medicines that improve
the functioning of the body's immune system to inhibit the growth and spread of cancer cells …

The year 2020 will be remembered as a most challenging year, and this was true at JAMA
Otolaryngology–Head & Neck Surgery. Our editorial board meeting was held in Chicago …